CAROLYN STRAPPINI: Open Payments
NPI 1720663008 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Liquidia Technologies, Inc. | 1 | $29 |
| United Therapeutics Corporation | 1 | $23 |
| Grifols USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, NUCALA, YUTREPIA, BREZTRI, Tyvaso, Prolastin-C Liquid.
Industry payments across CO — which companies pay providers there.
